A phase 1, open-label study of pasireotide in patients with BRAF- and NRAS wild type, unresectable, and/or metastatic melanoma

Details

Serval ID
serval:BIB_9AB4FCA2FF27
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
A phase 1, open-label study of pasireotide in patients with BRAF- and NRAS wild type, unresectable, and/or metastatic melanoma
Journal
ESMO Open
Author(s)
Dummer R., Michielin O.A., Nägeli M., Goldinger S.M., Campigotto F., Kriemler-Krahn U., Schmid H., Pedroncelli A., Micaletto S., Schadendorf D.
Publication state
In Press
Language
english
Create date
11/06/2018 16:25
Last modification date
21/08/2019 6:36
Usage data